Pharmacy Business Tracker Now Available

Neratinib

2023-03-24T17:08:33+03:00

HER2-overexpressing breast cancer: Extended adjuvant treatment of early-stage disease: [...]

Neratinib2023-03-24T17:08:33+03:00

Lenvatinib

2023-03-24T17:56:09+03:00

Locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid [...]

Lenvatinib2023-03-24T17:56:09+03:00

Lapatinib

2023-03-24T17:59:05+03:00

Advanced or metastatic HER2-overexpressing breast cancer: PO 1250mg OD [...]

Lapatinib2023-03-24T17:59:05+03:00

Irinotecan

2023-03-25T12:09:33+03:00

1st line treatment metastatic colorectal cancer: Combination therapy: Regimen [...]

Irinotecan2023-03-25T12:09:33+03:00
Go to Top